The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2017

Filed:

Sep. 18, 2015
Applicant:

Valencia Technologies Corporation, Valencia, CA (US);

Inventors:

Jeffrey H. Greiner, Valencia, CA (US);

David K. L. Peterson, Valencia, CA (US);

Chuladatta Thenuwara, Castaic, CA (US);

Stacy Greiner Chambliss, Valencia, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/375 (2006.01); A61H 39/00 (2006.01); A61N 1/36 (2006.01); A61N 1/372 (2006.01); A61F 5/00 (2006.01); A61N 1/378 (2006.01);
U.S. Cl.
CPC ...
A61H 39/002 (2013.01); A61F 5/0026 (2013.01); A61N 1/36085 (2013.01); A61N 1/36117 (2013.01); A61N 1/36125 (2013.01); A61N 1/36175 (2013.01); A61N 1/375 (2013.01); A61N 1/3756 (2013.01); A61N 1/37205 (2013.01); A61H 2201/50 (2013.01); A61H 2201/5005 (2013.01); A61H 2201/5038 (2013.01); A61H 2201/5097 (2013.01); A61N 1/36153 (2013.01); A61N 1/36157 (2013.01); A61N 1/3758 (2013.01); A61N 1/3782 (2013.01); Y10T 29/49117 (2015.01);
Abstract

An exemplary method of treating obesity or dyslipidemia of a patient using a small implantable electroacupuncture device (IEAD) includes 1) implanting the IEAD below the skin surface of the patient at or near a target tissue location selected from the group of target tissue locations comprising acupoints ST36, SP4, ST37, ST40, SP6, SP9, K16, LR8 and their underlying nerves, the saphenous nerve and the peroneal nerve, and 2) enabling the IEAD to provide EA stimulation pulses in accordance with a stimulation regimen that provides a stimulation session having a duration of T3 minutes at a rate of once every T4 minutes, where the ratio of T3/T4 is no greater than 0.05, and wherein T3 is at least 10 minutes and no greater than 60 minutes.


Find Patent Forward Citations

Loading…